Dr. Hitoshi Nakagama, President, Japan Agency for Medical Research and Development (AMED)
In this interview, Dr. Nakagama discusses U.S.-Japan research collaboration, AI-driven drug discovery, and Japan’s clinical trial environment.
For much of the period since Japan’s asset bubble burst, corporate strategy centered on cutting back.
Esta matéria foi publicada por The Report Company. O Lista de Publishers não reproduz o conteúdo — a leitura na íntegra é no portal de origem.
Ver a matéria na íntegra em the-report.com
Mais de The Report Company
In this interview, Dr. Nakagama discusses U.S.-Japan research collaboration, AI-driven drug discovery, and Japan’s clinical trial environment.
In an exclusive interview, Chairman Kobayashi discusses supply chain partnerships, business succession, and Japan–U.S. investment ties.
Japan’s companies are showing a greater appetite for investment and risk, and are increasingly open to M&A and partnerships with foreign firms.
Founded in 2007, Wazen is a trusted local partner in Libya’s oil and gas sector.
How a leading Libyan law firm helps international investors navigate opportunity, risk, and growth.
Petro Air pairs international aviation standards with deep knowledge of Libya’s energy sector.
Toda semana, no seu e-mail
Veículos que entraram no catálogo, movimentos de audiência e o que a medição começou a mostrar sobre a imprensa digital brasileira. Escrita por quem opera o robô, sem release.
Uma vez por semana mandamos o que mudou na base — veículos novos, movimentos de audiência e o que a medição começou a mostrar.